Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
Also known as: Diffuse large B-cell lymphoma associated with chronic inflammation (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB11930 | Varlilumab | 2 | Active Not Recruiting | 1 |
| DB15035 | Zanubrutinib | 2 | Recruiting | 1 |
| DB00928 | Azacitidine | 2 / 3 | Recruiting | 1 |
| DB14681 | Cortisone | 2 / 3 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 / 3 | Recruiting | 1 |
| DB00997 | Doxorubicin | 2 / 3 | Recruiting | 1 |
| DB00959 | Methylprednisolone | 2 / 3 | Recruiting | 1 |
| DB00635 | Prednisone | 2 / 3 | Recruiting | 1 |
| DB00073 | Rituximab | 2 / 3 | Recruiting | 1 |
| DB14546 | Sulfate ion | 2 / 3 | Recruiting | 1 |
| DB00541 | Vincristine | 2 / 3 | Recruiting | 1 |